Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chronic Urinary Retention: Comparative Effectiveness and Harms of Treatments [Internet].
Brasure M, Fink HA, Risk M, MacDonald R, Shamliyan T, Ouellette J, Xu D, Butler M, Kane RL, Wilt TJ. Brasure M, et al. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Sep. Report No.: 14-EHC041-EF. Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Sep. Report No.: 14-EHC041-EF. PMID: 25275205 Free Books & Documents. Review.
Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostaic Hyperplasia: A Review [Internet].
Brasure M, MacDonald R, Dahm P, Olson CM, Nelson VA, Fink HA, Risk M, Rwabasonga B, Wilt TJ. Brasure M, et al. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 May. Report No.: 16-EHC024-EF. Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 May. Report No.: 16-EHC024-EF. PMID: 27336104 Free Books & Documents. Review.
Primary cryotherapy for localised or locally advanced prostate cancer.
Jung JH, Risk MC, Goldfarb R, Reddy B, Coles B, Dahm P. Jung JH, et al. Among authors: risk mc. Cochrane Database Syst Rev. 2018 May 30;5(5):CD005010. doi: 10.1002/14651858.CD005010.pub3. Cochrane Database Syst Rev. 2018. PMID: 29845595 Free PMC article. Review.
Pembrolizumab monotherapy versus chemotherapy for treatment of advanced urothelial carcinoma with disease progression during or following platinum-containing chemotherapy. A Cochrane Rapid Review.
Narayan V, Kahlmeyer A, Dahm P, Skoetz N, Risk MC, Bongiorno C, Patel N, Hwang EC, Jung JH, Gartlehner G, Kunath F. Narayan V, et al. Among authors: risk mc. Cochrane Database Syst Rev. 2018 Jul 23;7(7):CD012838. doi: 10.1002/14651858.CD012838.pub2. Cochrane Database Syst Rev. 2018. PMID: 30036453 Free PMC article. Review.
Re: Maxine Sun, Lorenzo Marconi, Tim Eisen, et al. Adjuvant Vascular Endothelial Growth Factor-targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled Analysis. Eur Urol 2018;74:611-20: Systematic Review Findings on the Role of Adjuvant Vascular Endothelial Growth Factor-targeted Therapy in Renal Cell Carcinoma.
Hwang EC, Risk MC, Dahm P. Hwang EC, et al. Among authors: risk mc. Eur Urol. 2019 Mar;75(3):e67-e68. doi: 10.1016/j.eururo.2018.11.006. Epub 2018 Nov 19. Eur Urol. 2019. PMID: 30466889 No abstract available.
32 results